Esperion Therapeutics Inc (ESPR) earnings · rev $403.1M
These earnings events as JSON? API free 100/dayEsperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This ESPR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ESPR revenue for 2025-12-31 was $403.1M. Net income was -$22.7M. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. ESPR currently screens at market cap $816.9M.
When the next ESPR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 21.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ESPR research stays on the stock page; the tape stays on the quote page.
ESPR earnings FAQ
What are ESPR's latest revenue and net income?
Latest cached Esperion Therapeutics Inc (ESPR) revenue for Dec 31, 2025 was $403.1M. Net income was -$22.7M. Statements: https://lician.com/financials/espr
What is ESPR's latest diluted EPS?
Latest cached Esperion Therapeutics Inc (ESPR) diluted EPS for Dec 31, 2025 was -$0.11.
What period does the latest ESPR earnings print cover?
The latest cached Esperion Therapeutics Inc (ESPR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ESPR revenue change from the prior cached period?
Cached Esperion Therapeutics Inc (ESPR) revenue was up 21.3% from $332.3M (Dec 31, 2024) to $403.1M (Dec 31, 2025). Statements: https://lician.com/financials/espr
Where are ESPR earnings listed?
Cached earnings facts for Esperion Therapeutics Inc (ESPR) are listed at https://lician.com/earnings/espr. Statements: https://lician.com/financials/espr
Not investment advice.